Colin V. Gegg

Design and Synthesis of Conformationally Constrained Glucagon-Like Peptide-1 Derivatives with Increased Plasma Stability and Prolonged in Vivo Activity

Les P. Miranda, Katherine A. Winters, Colin V. Gegg et al. · Journal of Medicinal Chemistry · 2008 · 81 citations · Full text

Engineering, Peptide Engineering, Glycobiology +18

Ligand-Binding Mass Spectrometry to Study Biotransformation of Fusion Protein Drugs and Guide Immunoassay Development: Strategic Approach and Application to Peptibodies Targeting the Thrombopoietin Receptor

Michael Hall, Colin V. Gegg, Kenneth W. Walker et al. · The AAPS Journal · 2010 · 59 citations · Full text

Thrombopoietin Receptor, Medicine, Natural Sciences +14

An Acyl-Ghrelin-Specific Neutralizing Antibody Inhibits the Acute Ghrelin-Mediated Orexigenic Effects in Mice

Shu-Chen Lu, Jing Xu, Narumol Chinookoswong et al. · Molecular Pharmacology · 2009 · 56 citations

Probing minimal independent folding units in dihydrofolate reductase by molecular dissection

Colin V. Gegg, Katherine Bowers, C. Robert Matthews · Protein Science · 1997 · 54 citations · Full text

Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3

Justin K. Murray, Yixin Qian, Benxian Liu et al. · Journal of Medicinal Chemistry · 2015 · 46 citations · Full text

Peptide Engineering, Synaptic Transmission, Peptide Science +18